by
Jay Motola on Prostate
Monday, December 05 2011
The PSA test seems fairly straight-forward. So why should there be a controversy?
Having been involved in urology prior to the widespread use of PSA testing, I and many other urologists have unfortunately spent time on the wards of hospitals that had numerous patients who were hospitalized as a result of the side effects of advanced... Read more
by
Jay Motola on Prostate
Tuesday, October 25 2011
On a daily basis, patients ask, “Doctor what are the symptoms of prostate cancer?” When I tell them that most cases of prostate cancer do not include symptoms, the patients are very surprised.
Prostate cancer presently is diagnosed in the early stages. These early cases of prostate cancer are usually diagnosed via a combination... Read more
by
Jay Motola on Prostate
Wednesday, October 19 2011
By now you have begun to recuperate from your surgery to remove your prostate cancer. The catheter is out and you have been cured of your cancer, however you are experiencing urinary incontinence, the involuntary loss of urine.
This is a scenario that we see in the office many times after radical surgery. Many patients go into these... Read more
Drugs that fall into the category of 5-alpha reductase inhibitors (5 ARIs), such as Avodart (dutasteride) and Proscar (finasteride) have recently been in the news. These drugs have previously been approved to treat the symptoms of prostate enlargement by causing the prostate to shrink in size. Propecia, which is a 1 mg dose of... Read more
Mitomycin C is a naturally derived chemotherapy that is isolated from the streptomyces bacteria. This drug is used for the treatment of various cancers, but in Urology it is used for the treatment of superficial bladder cancer, the most common type of bladder cancer that is diagnosed. Over 70,000 cases of bladder cancer are diagnosed in the... Read more
